Hydrogen sulfide's role in preventing glioblastoma growth
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
This study is looking at how hydrogen sulfide might help fight glioblastoma, a tough type of brain cancer, especially in older patients, and it explores ways to change hydrogen sulfide levels through diet or medication to find new treatments for this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11042844 on NIH RePORTER |
What this research studies
This research investigates how hydrogen sulfide (H2S) can act as a tumor suppressor in glioblastoma, the most common malignant brain tumor in adults. The study focuses on understanding the effects of advanced age on cancer stem cells and how H2S influences their maintenance and tumor growth. By exploring dietary and pharmacological methods to modulate H2S levels, the research aims to uncover new therapeutic strategies for glioblastoma treatment. Patients may be involved in trials assessing these interventions and their impact on tumor progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 65 and older who are diagnosed with glioblastoma.
Not a fit: Patients under the age of 65 or those without a diagnosis of glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that effectively slow down or prevent the growth of glioblastoma in patients.
How similar studies have performed: While the role of hydrogen sulfide in cancer is being explored, this specific approach in glioblastoma is relatively novel and has not been extensively tested.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Hine, Christopher Michael — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Hine, Christopher Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.